Adc Therapeutics Sa (ADCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -142,623 | -157,846 | -240,053 | -157,128 | -230,026 |
| Depreciation Amortization | 1,876 | 3,276 | 3,267 | 2,388 | 2,630 |
| Income taxes - deferred | N/A | N/A | 37,104 | -1,621 | -26,049 |
| Accounts receivable | -8,789 | 4,771 | 47,789 | -42,753 | -30,218 |
| Accounts payable and accrued liabilities | -9,038 | 2,462 | 3,173 | 310 | 6,798 |
| Other Working Capital | -25,355 | 3,826 | 45,987 | -48,725 | -15,710 |
| Other Operating Activity | 42,755 | 19,676 | -15,953 | 109,218 | 59,197 |
| Operating Cash Flow | $-141,174 | $-123,835 | $-118,686 | $-138,311 | $-233,378 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 395 | -867 | -3,216 | -687 | -3,430 |
| Purchase Sale Intangibles | N/A | N/A | N/A | N/A | -2,946 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -3,243 |
| Investing Cash Flow | $395 | $-867 | $-3,216 | $-687 | $-6,673 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 115,597 | 49,591 |
| Debt Repayment | N/A | N/A | N/A | -118,304 | N/A |
| Common Stock Issued | 152,459 | 98,217 | 773 | 6,130 | 778 |
| Other Financing Activity | -1,514 | -1,163 | 73,102 | -4,320 | 217,025 |
| Financing Cash Flow | $150,945 | $97,054 | $73,875 | $-897 | $267,394 |
| Exchange Rate Effect | 305 | -83 | 184 | -208 | 6 |
| Beginning Cash Position | 250,867 | 278,598 | 326,441 | 466,544 | 439,195 |
| End Cash Position | 261,338 | 250,867 | 278,598 | 326,441 | 466,544 |
| Net Cash Flow | $10,471 | $-27,731 | $-47,843 | $-140,103 | $27,349 |
| Free Cash Flow | |||||
| Operating Cash Flow | -141,174 | -123,835 | -118,686 | -138,311 | -233,378 |
| Capital Expenditure | -264 | -867 | -3,216 | -687 | -3,430 |
| Free Cash Flow | -141,438 | -124,702 | -121,902 | -138,998 | -236,808 |